Loxo Oncology

Loxo Oncology is a biopharmaceutical company focused on developing and commercializing highly selective drugs for cancer patients defined by genomic characteristics. The company is developing a series of targeted therapies with an emphasis on treating cancers that depend on a single genetic abnormality, which can be detected through genomic testing. For cancer patients carrying these genomic alterations, targeted drugs hold significant potential for cancer treatment.